Skip to content

Clinical trials

Phase 2 Bone Diseases, Metabolic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Diseases, Metabolic Phase: Phase 2 Country / region: United States Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20042
20051
20061
20071
20081
20102
20115
20132
20142
20152
20192
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated3
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Northwestern University4
Massachusetts General Hospital3
Children's Hospital Medical Center, Cincinnati2
National Cancer Institute (NCI)2
Thomas J. Schnitzer2
Columbia University1
Creighton University1
Emory University1
Harvard University Faculty of Medicine1
Iowa State University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Diseases, Metabolic28
Osteoporosis19
Spinal Cord Injuries6
Bone Diseases5
Musculoskeletal Diseases4
Spinal Cord Diseases4
Central Nervous System Diseases3
Fractures, Bone3
HIV Infections3
Nervous System Diseases3

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.